RENBP and diabetes mellitus: Potential targets are mainly enriched in the AGE-RAGE signaling pathway in diabetes complications, lipids and atherosclerosis, fluid shear stress and atherosclerosis, IL-17 signaling pathway, TNF signaling pathway, and others.